Clinical Data Income Statement
View: Annual | Quarterly
| Mar 09 | Mar 08 | Mar 07 | |
|---|---|---|---|
| Revenue | 10.4 | 34.0 | 63.7 |
| Cost of Goods Sold | 6.5 | 26.3 | 40.9 |
| Gross Profit | 4.0 | 7.8 | 22.8 |
| Gross Profit Margin | 37.9% | 22.8% | 35.8% |
| SG&A Expense | 27.5 | 37.4 | 36.5 |
| Depreciation & Amortization | 1.7 | 6.6 | 10.3 |
| Operating Income | (121.9) | (45.6) | (25.9) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.2 | 0.5 | 0.9 |
| Nonoperating Expenses | (1.1) | 1.5 | -- |
| Income Before Taxes | (123.7) | (46.1) | (26.5) |
| Income Taxes | 0.0 | (0.0) | 1.4 |
| Net Income After Taxes | (123.7) | (46.1) | (27.9) |
| Continuing Operations | (123.7) | (46.1) | (27.9) |
| Discontinued Operations | (8.8) | 10.8 | (9.6) |
| Total Operations | (132.4) | (35.3) | (37.5) |
| Total Net Income | (132.4) | (35.3) | (37.5) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (6.03) | (1.85) | (2.65) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
